NMRA
Neumora Therapeutics, Inc.Company with tickers: NMRA
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-02-17 | Milligan Michael Lee | Officer | 1,436 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | BERNS PAUL L | Officer | 9,819 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Pinto Joshua | Officer | 5,967 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Aurora Daljit Singh | Officer | 6,165 | 2026-02-17 | Merrill Lynch |
| 2025-11-12 | Aurora Family Trust | Director, Officer | 114,703 | 2025-11-11 | Merrill Lynch |
| 2025-03-12 | Henry Gosebruch | Officer, Director | 15,000 | 2025-03-12 | J.P. Morgan Securities LLC |
| 2025-02-18 | Pinto Joshua | Officer | 8,048 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Gosebruch Henry O | Officer, Director | 6,857 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Aurora Daljit Singh | Officer | 8,565 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Suh Carol Y. | Officer | 9,540 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | BERNS PAUL L | Officer | 13,871 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Lenz Robert A. | Officer | 5,614 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Milligan Michael Lee | Officer | 1,978 | 2025-02-18 | Merrill Lynch |
| 2024-10-18 | Fust Matthew K | Director | 14,049 | 2024-10-18 | Merrill Lynch |
| 2024-10-17 | Fust Matthew K | Director | 7,739 | 2024-10-17 | Merrill Lynch |
| 2024-10-10 | Lenz Robert A. | Officer | 8,260 | 2024-10-10 | Merrill Lynch |
| 2024-10-09 | Lenz Robert A. | Officer | 5,563 | 2024-10-09 | Merrill Lynch |
| 2024-09-18 | Lenz Robert A. | Officer | 10,676 | 2024-09-18 | Merrill Lynch |
| 2024-09-17 | Lenz Robert A. | Officer | 30,788 | 2024-09-17 | Merrill Lynch |
| 2024-09-12 | Lenz Robert A. | Officer | 32,948 | 2024-09-12 | Merrill Lynch |
| 2024-08-22 | Pinto Joshua | Officer | 100,000 | 2024-08-22 | Merrill Lynch |
Showing 1–21 of 21 filings